Terumo (OTCMKTS:TRUMY) Shares Gap Up – Time to Buy?

Terumo Corp. (OTCMKTS:TRUMY) shares gapped up before the market opened on Tuesday . The stock had previously closed at $13.25, but opened at $13.9601. Terumo shares last traded at $13.98, with a volume of 39,095 shares changing hands.

Analysts Set New Price Targets

Separately, Zacks Research upgraded shares of Terumo to a “hold” rating in a research report on Thursday, April 9th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has an average rating of “Hold”.

Terumo Trading Up 2.6%

The company has a market capitalization of $20.71 billion, a PE ratio of 23.02 and a beta of 0.68. The company has a current ratio of 1.59, a quick ratio of 0.97 and a debt-to-equity ratio of 0.06. The stock has a fifty day moving average of $14.01 and a two-hundred day moving average of $13.53.

Terumo (OTCMKTS:TRUMY) last issued its earnings results on Friday, May 15th. The company reported $0.11 EPS for the quarter, hitting the consensus estimate of $0.11. Terumo had a net margin of 12.09% and a return on equity of 9.17%. The company had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.84 billion. As a group, sell-side analysts anticipate that Terumo Corp. will post 0.7 earnings per share for the current fiscal year.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.